DAYANG BIOTECH: The Zhejiang Regulatory Bureau has taken corrective measures against the company's shareholder Yang Xingli and his concerted actors
I'm PortAI, I can summarize articles.
DAYANG BIOTECH announced that the Zhejiang Regulatory Bureau has taken corrective measures against shareholder Yang Xingli and his concerted actors. After Yang Xingli held more than 5% of the shares, his concerted actors failed to promptly notify the company of their 1% increase in shareholding, violating relevant acquisition management regulations
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments